NEW YORK, March 14, 2017 /PRNewswire/ --
FinancialBuzz.com News Commentary
Accordingto Arcview Market Research, the regulated cannabis sales in North America totaled $6.9 billion in 2016, which is a 30 percent increase from 2015. Sales are projected to increase to
Troy Dayton, CEO of Arcview Market Research said in a statement, "The enormous amount of existing, if illicit, consumer spending sets cannabis apart from most other major consumer-market investment opportunities throughout history; the cannabis industry doesn't need to create demand for a new product or innovation - it just needs to move demand for an already widely-popular product into legal channels."
CURE Pharmaceutical Holding Corp. (OTCQB: CURR) announced yesterday after the market closed that, the U.S. Patent and Trademark Office (USPTO) has granted Patent #9,561,182, covering the method of manufacture and method of use of the company's proprietary oral thin film technology, for the administration of medicaments in order to treat animals.
"This patent adds an important aspect to our intellectual property portfolio, as it now ensures many of the same protections we enjoy in human products to animal products, which can be used in a variety of contexts, from households with pets to farms," said Rob Davidson, CEO of CURE Pharmaceutical. "This is also further validation of our unique approach to the development of oral thin film and our proprietary CureFilm technology."
"This action also represents an important expansion in the methodology, veterinarians may have, moving forward to deliver important medicines to the animals for whom they care," added Greg Strathe, DVM, CURE Pharmaceutical advisory board member, and co-owner SAHO, Small Animal Hospital of Owasso, Okla. "The expansion of our ability to improve care continues to be a priority for those in veterinary medicine, and I believe that this approach is a true innovation."
Axim Biotechnologies Inc. (OTCQB: AXIM) focuses on the research, development and production of cannabis-based pharmaceutical, nutraceutical and cosmetic products. Its flagship products include CanChew Plus®, a CBD-based controlled release chewing gum, and MedChew Rx®; a combination CBD/THC gum, that will be undergoing clinical trials for the treatment of pain and spasticity associated with multiple sclerosis. Axim Biotechnologies recently enrolled 40 patients to begin Phase II Trial, for the treatment of Irritable Bowel Syndrome (IBS) with CanChew Plus® cannabidiol chewing gum. Selected from a pool of over 400 patients, 40 trial patients aged 18-65 will be subject to a randomized, double-blind, cross-over trial of 8 weeks. Patients will receive a maximum 6 chewing gums per day, either containing 50 mg of cannabidiol per chewing gum, in case of the CanChew chewing gum, or a placebo chewing gum.
General Cannabis Corporation (OTCQB: CANN) is a resource company for the highest quality service providers, available to the regulated Cannabis Industry. The company lease growing space and related facilities, such as commercial real estate and equipment, to licensed marijuana business operators for their production needs. Also, they pursue ancillary business products, regulatory compliance consulting, and advanced logistical support for grow operations. Its subsidiary, Iron Protection Group, provides security and training services to government agencies, multinational corporations, diplomats, dignitaries and non-profit organizations, both domestic and abroad. Iron Protection Group encompasses all things related to protection, from training individuals in the art of manipulating a firearm, all the way to providing a personal security detail for any security needs.
Cannabis Sativa Inc. (OTCQB: CBDS) through its subsidiaries, develops, manufactures, and sells herbal based skin care products in the United States and internationally. It offers herbal based line of products, such as Go Deep, a deep penetrating healing salve that reduces pain and inflammation when massaged into muscles, ligaments, tendons, and joints; Go Deep EXTRA, a deep penetrating pain relief ointment for use in mitigating migraine and sinus headaches; Face Garden, an antioxidant and moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also engages in the research, development, and licensing of natural cannabis products comprising cannabis formulations, edibles, topicals, strains, recipes, and delivery systems.
Medicine Man Technologies Inc. (OTCQB: MDCL) provides consulting services for cannabis growing technologies and methodologies, as well as retail operations of cannabis products. The Company focuses on providing assistance to its clients, in various businesses related to the cannabis industry, including cultivation; the dispensary business model, including combinations and other variables related to the retail model configuration of both a medical, as well as adult use (recreational) operation, and other areas, including but not limited to business plan generation, financial pro forma generation, application generation support, recommendations for other service providers, employee training and facility design services. It offers a separate cultivation or dispensary license and other related consultative services. It offers both pre-license consulting, as well as licensure services that generally tie to the size of the proposed business venture.
Please Sign Up Now at http://www.FinancialBuzz.com to Receive Alerts on Trending Financial News from all these companies. 'The Latest Buzz in Financial News'
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook like us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
For further information: Media Contact: E-mail: firstname.lastname@example.org Phone: +1-877-601-1879
Subscribe to our Free Newsletters!
Adrenalectomy is a surgery that involves removing either one or both the adrenal glands.
Craniosynostosis is a condition where the bones of the skull are fused together prematurely ...
Episiotomy is a surgical incision made in the perineum between the vaginal orifice and the anus ...View All